Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95 | -$189 | -$142 | -$73 |
| Dep. & Amort. | $2 | $0 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $48 | $39 | $27 | $13 |
| Change in WC | $26 | $9 | $7 | $3 |
| Other Non-Cash | -$59 | -$7 | -$2 | $8 |
| Operating Cash Flow | -$78 | -$147 | -$110 | -$49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$0 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$659 | -$444 | -$394 | $0 |
| Inv. Sales/Matur. | $394 | $575 | $139 | $0 |
| Other Inv. Act. | $36 | -$3 | -$0 | $0 |
| Investing Cash Flow | -$231 | $128 | -$255 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $178 | $161 | $162 | $167 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25 | $3 | $4 | $130 |
| Financing Cash Flow | $203 | $164 | $166 | $297 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$106 | $146 | -$199 | $241 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $231 | $85 | $284 | $44 |
| End Cash | $125 | $231 | $85 | $284 |
| Free Cash Flow | -$80 | -$150 | -$110 | -$57 |